Lipigon Pharmaceuticals ABLipigon Pharmaceuticals AB - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

The Disclosure score covers 17 UN Sustainable Development Goals including: 'Good Health & Wellbeing', 'Sustainable Cities & Communities' and 'Peace, Justice & Strong Institutions'. If you are employed by Lipigon Pharmaceuticals AB and you would like to use your Sustainability aseessment, please get in touch. The page contains a Q&A table for Lipigon Pharmaceuticals AB.

Lipigon Pharmaceuticals AB in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.8; made up of an environmental score of 4.0, social score of 8.0 and governance score of 5.3.

SDG Transparency Score for Lipigon Pharmaceuticals AB 
Low
0 - 3

5.8

Medium Impact
4 - 6
High
7 - 10
Last Score Update: 2024-05-01
What drives the score for Lipigon Pharmaceuticals AB 
4.0

Environmental

8.0

Social

5.3

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Caladrius Biosciences Inc
8.0
High
1Can Fite Biopharma Ltd
8.0
High
521Smruthi Organics Ltd
5.9
High
521Vectura Group PLC
5.9
High
541Lipigon Pharmaceuticals AB
5.8
High
541Cantargia AB
5.8
High
541Amplia Therapeutics Ltd
5.8
High
.........
1970Zyden Gentec Ltd
0.0
Low
1970iNtRON Biotechnology Inc
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Lipigon Pharmaceuticals AB have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Lipigon Pharmaceuticals AB disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Lipigon Pharmaceuticals AB report the average age of the workforce?

LockedSign up for free to unlock

Does Lipigon Pharmaceuticals AB reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Lipigon Pharmaceuticals AB disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Lipigon Pharmaceuticals AB disclose cybersecurity risks?

LockedSign up for free to unlock

Does Lipigon Pharmaceuticals AB offer flexible work?

LockedSign up for free to unlock

Does Lipigon Pharmaceuticals AB have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Lipigon Pharmaceuticals AB disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Lipigon Pharmaceuticals AB conduct supply chain audits?

LockedSign up for free to unlock

Does Lipigon Pharmaceuticals AB disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Lipigon Pharmaceuticals AB conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Lipigon Pharmaceuticals AB disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Lipigon Pharmaceuticals AB disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Lipigon Pharmaceuticals AB disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Lipigon Pharmaceuticals AB disclose water use targets?

LockedSign up for free to unlock

Does Lipigon Pharmaceuticals AB have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Lipigon Pharmaceuticals AB have a product recall in the last two years?

LockedSign up for free to unlock

Does Lipigon Pharmaceuticals AB disclose incidents of discrimination?

LockedSign up for free to unlock

Does Lipigon Pharmaceuticals AB allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Lipigon Pharmaceuticals AB issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Lipigon Pharmaceuticals AB disclose parental leave metrics?

LockedSign up for free to unlock

Does Lipigon Pharmaceuticals AB disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Lipigon Pharmaceuticals AB disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Lipigon Pharmaceuticals AB disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Lipigon Pharmaceuticals AB support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Lipigon Pharmaceuticals AB disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Lipigon Pharmaceuticals AB reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Lipigon Pharmaceuticals AB involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Lipigon Pharmaceuticals AB disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Lipigon Pharmaceuticals AB disclose its waste policy?

LockedSign up for free to unlock

Does Lipigon Pharmaceuticals AB report according to TCFD requirements?

LockedSign up for free to unlock

Does Lipigon Pharmaceuticals AB disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Lipigon Pharmaceuticals AB disclose energy use targets?

LockedSign up for free to unlock

Does Lipigon Pharmaceuticals AB disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Lipigon Pharmaceuticals AB have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Lipigon Pharmaceuticals AB
These potential risks are based on the size, segment and geographies of the company.

Lipigon Pharmaceuticals AB (publ) develops drugs for lipid related diseases in Sweden. The company's product pipeline consists of Lipisense project for the treatment of severe hypertriglyceridemia disease and familial chylomicronemia syndrome; a gene therapy project for the lipodystrophy, a rare disease of altered fat distribution in the body; therapeutics for dyslipidemia, a general lipid disorder; and RNA drug project for acute respiratory distress syndrome. Lipigon Pharmaceuticals AB (publ) has a collaboration agreement with HitGen Inc. for the development of small molecules for the treatment of dyslipidemia, cardiovascular disease, and other metabolic diseases. The company was founded in 2010 and is based in Umeå, Sweden.

Sorry!

Failed to process!